Gene expression may predict peritoneal mesothelioma survival

Baltimore scientists believe they have found a way to improve predict C and finally C for survival in patients with malignant peritoneal mesothelioma (MPM).

Peritoneal Mesothelioma is a rare cancer of the lining of the abdominal cavity. Like other forms of mesothelioma caused by asbestos mineral fibers. If it is almost always fatal, people with peritoneal mesothelioma tends to very different reactions to disease.

The researchers attempted to explain the reasons for this variability and the response can grow in the signaling pathways that cancer cells and multiply to determine said. Experiment in tumor samples from 41 patients with mesothelioma, the researchers analyzed the genes expressed by each group of cells. What they have found a significant difference in the chemical signaling for the synthesis of proteins and RNA in the cells.

is overexpressed in a group known signaling pathways phosphoinositide 3-kinase (PI3K) and the objective of monitoring the interaction of the mammalian rapamycin (mTOR). were in cases in which the genes present produced by these channels, the patients with peritoneal mesothelioma who received a median of 24 months.

But in cases where these channels and their corresponding genes were not found, mesothelioma patients have a median survival of 69.5 months. To test his theory that were, these cellular pathways to cancer cell proliferation and prognosis to inhibit the researchers used a chemical to P13K and mTOR signaling pathways in the cell samples. They found that when these channels are inhibited cell signaling and cell proliferation were significantly reduced.

The study was conducted by the Department of Surgical Oncology at the University of Maryland School of Medicine, Baltimore conducted and published in an upcoming issue of Cancer.

Plumber still show a high risk of mesothelioma studies

Installers are among the industrial workers at high risk for the deadly cancer mesothelioma. This is the result of a study by the insurance industry recently in the United Kingdom.

The report, prepared for the demands of Nacional, found that have plumbers and pipe fitters and current or former electrician, construction worker and auto mechanic, a significantly higher incidence of cancers associated with asbestos, that people who work in other industries. Itsa find support from researchers at the CDC in the United States displaying the number of deaths of plumbers and pipefitters Mesothelioma significantly predict the number will rise and continue for another 40 years.

Asbestos is an insulating material was widely used in industry around the world before 1980. It has been estimated mainly pipes for their resistance to extreme temperatures and corrosion. Although no longer used in new buildings and even C in over 40 countries (not USA) asbestos remaining C for water pipes and fittings and radiator filaments of millions of old houses and commercial buildings is prohibited. Plumbers and pipefitters to disturb the asbestos in the cup, the repair or replacement, it can toxic fibers to release the seeds of mesothelioma, lung cancer, asbestosis and other diseases.

The report warns that insurance in the UK plumbers, past and present, that a disease mesothelioma, which is particularly dangerous because it tends to grow slowly, with symptoms that can simulate different conditions, making it less likely until the disease is diagnosed in its final phase. According to the report of asbestosis symptoms are often only 15-20 years after the first exposure to asbestos. The symptoms begin and can be stronger in some years. Common symptoms are shortness of breath (at first, then physical activity and may occur at rest), cough, wheezing and chest pain.

Meanwhile, the Daily Telegraph UK's 175,000 payment to a former hospital reported plumber diagnosed with mesothelioma. Sixty-one years Ward Alan Westin credit-super-Mare, has never ever been warned against the dangers of inhaling asbestos. We just broke out of asbestos and has to work, said Ward. Ward in a hospital in Wakefield in 1964 worked until 1972.

Phase II study for patients with mesothelioma begin

Drug discovery and development of companies Bionomics Australia intends to start a Phase II clinical trial discontinued with the agent BNC105 in patients with mesothelioma.

Mesothelioma is a rare form of cancer caused mainly by natural asbestos minerals. Most people diagnosed with mesothelioma were first being exposed to asbestos through the manipulation of materials containing asbestos in the use of toxic minerals was a common practice.

Today, many states strict rules on the use of asbestos in products. In addition to a high rate in Australia, malignant mesothelioma affects approximately 2000-3000 people in the United States each year.

The phase II BNC105 is a study of patients with mesothelioma who have experienced progression after chemotherapy with platinum pemetrexed.
While trying to BNC105 the patients in the first days and eight cycles are administered 21 days. The treatment is continued until tumor progression evident.

According to Deborah Rathjen, CEO and Chairman of Bionomics, should the provisional results of the study in early 2011 will be available.

Additional information can be found on mesothelioma, even if the center of mesothelioma.